Acute Graft-versus-Host-Disease Other Than Typical Targets: Between Myths and Facts.
Mariotti J, Penack O, Castagna L.
Transplant Cell Ther. 2021 Feb;27(2):115-124. doi: 10.1016/j.bbmt.2020.09.033. Epub 2020 Oct 2.
Graft-versus-host disease.
Gatti RA, Kersey JH, Yunis EJ, Good RA.
Prog Clin Pathol. 1973;5:1-18.
Acute graft versus host disease.
Jacobsohn DA, Vogelsang GB.
Orphanet J Rare Dis. 2007 Sep 4;2:35. doi: 10.1186/1750-1172-2-35.
The graft-versus-leukemia effect.
Mavroudis D, Barrett J.
Curr Opin Hematol. 1996 Nov;3(6):423-9. doi: 10.1097/00062752-199603060-00005.
Regulatory mechanisms in graft-versus-host responses.
Edinger M, Powrie F, Chakraverty R.
Biol Blood Marrow Transplant. 2009 Jan;15(1 Suppl):2-6. doi: 10.1016/j.bbmt.2008.10.013.
Graft-versus-host reaction and GvH disease.
Harada T.
Tohoku J Exp Med. 1994 May;173(1):171-81. doi: 10.1620/tjem.173.171.
Separating graft-versus-tumor from graft-versus-host reactions.
Fassas AB, Morris C, Badros A, Van Rhee F, Tricot G.
Leuk Lymphoma. 2002 Apr;43(4):725-33. doi: 10.1080/10428190290016818.
Hematopoietic factors in graft-versus-host reaction.
Kanamaru A, Hara H.
Int J Cell Cloning. 1987 Nov;5(6):450-62. doi: 10.1002/stem.5530050603.
Graft-versus-host reaction and rejection after experimental small-bowel transplantation. Minireview based on a doctoral thesis.
Johnsson C.
Ups J Med Sci. 1995;100(2):53-92. doi: 10.3109/03009739509178897.
Treatment of an established graft-versus-host reaction in AKR mice by adoptive immunotherapy.
Chester SJ, Esparza AR, Albala MM.
Cancer Res. 1975 Mar;35(3):634-6.
